Sign up
Log in
Immunovant Q3 Earnings Assessment
Share
Listen to the news

Immunovant (NASDAQ:IMVT) announced its Q3 earnings on Friday, February 6, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

Immunovant beat estimated earnings by 14.08%, reporting an EPS of $-0.61 versus an estimate of $-0.71.

Revenue was down $0 from the same period last year.

Previous Earnings Records

Last quarter the company missed on EPS by $0.01 which was followed by a 2.05% drop in the share price the next day.

To track all earnings releases for Immunovant visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
Terms of Service·Privacy Policy·Data Disclaimer
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved